维普期刊资源整合服务平台（V6.5）

439篇 您的检索式：作者名="BURRI HA"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreatic cancer: a randomized trial显示文摘	Burris HA Ⅲ Moore MJ Anderson J	1997	J Clin Oncol1997，15，6：	1
2	Improvements in sur- vival and clinical benefit with gemeitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial 显示文摘	Burris HA 3^rd Moore MJ Andersen J	1997	J Clin Oncal1997，15，：	1
3	Carcinoma ofunknown primary site显示文摘	Greco FA Burris HA 3rd Erland JB	2000	Cancer2000，89，12：	1
4	Phase Ⅱ trial of docetaxel in advanced anthraxcycline-resistant or anthraxcenedione-resistant breast cancer 显示文摘	Ravdin PM Burris HA Ⅲ Cook G	1995	J Clin Oncol1995，13，12：	1
5	A phase I study of GW572016 in patients with solid tumors显示文摘	Burris HA Taylor C Jones S	2003	Proc Am Soc Clin Oncol2003，22，：	1
6	Phase Ⅰ study of docetaxel administered by weekly infusion in patients with advanced refractory cancer显示文摘	Hainsworth JD Burris HA Erland JB	1998	J Clin Oncol1998，16，6：	1
7	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial 显示文摘	Burris HA 3rd Moore M J Andersen J	1997	J Clin Oncol1997，15，6：	1
8	Improvements in survival and clinical benefit with gemcitabine flrst-time therapy for patients with advanded pancreas cancer: Arandimized trial显示文摘	Burris HA Moore MJ Andersen J	1997	J Clin Oncol1997，15，：	1
9	Phase I,dose-escalation study of BKM120, an oral pan-Class I PI3Kinhibitor, in patients with advanced solid tumors 显示文摘	Bendell JC Rodon J Burris HA	2012	J ClinOncol2012，30，3：	1
10	Improve- ments in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial显示文摘	Burris HA 3rd Moore M J Andersen J	1997	J Clin Oncol1997，15，6：	1
11	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial 显示文摘	Burris HA 3rd Moore MJ Andersen J	1997	J Clin Oncol1997，15，6：	1
12	Weekly doeetaxel in the treatment of elderly patients with advanced breast cancer 显示文摘	Hainsworth JD Burris HA 3rd Yardley DA	2001	J Clin Oncol2001，19，15：	1
13	Phase I phar-macokinetic and pharmacodynamic study of the oral mammaliantarget of rapamycin inhibitor everolimus in patients with advancedsolid tumors显示文摘	O’DONNELL A FAIVRE S BURRIS HA	2008	J Clin Oncol2008，26，10：	1
14	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial显示文摘	Burris HA 3rd Moore MJ Andersen J	1997	J Clin Oncol1997，15，6：	1
15	A phase lI trial of gemcitabine/carboplatin with or without trastuzumab in the first- line treatment of patients with metastatic breast cancer显示文摘	Yardley DA Burris HA 3rd Simons L	2008	Clin Breast Cancer2008，8，5：	1
16	Phase Ⅱ trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer显示文摘	Shipley D Spigel DR Burris HA	2010	J Clin Oneol(Meeting Abstracts)2010，28，15：	1
17	Preclinical and phase Ⅰ trials of topoisomerase Ⅰ inhibitors 显示文摘	Von-Hoff DD Burris HA Eckardt J	1994	Cancer Chemother Pharmacol1994，，：	1
18	3rd,Docetaxel in combination with fluorouracil for advanced solid tumors显示文摘	Burris HA		0，，：	1
19	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial显示文摘	Burris HA 3rd Moore MJ Andersen J	1997	J Clin Oncol1997，15，6：	1
20	Phase II Trial of Bevacizumab and everolimus in patients with advanced renal cell carcinoma 显示文摘	Hainsworth JD Spigel DR Burris HA 3rd	2010	J Clin Oncol2010，，：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示